Interestingly, induction of SIRT-1 by resveratrol has been shown to ameliorate bleomycin-induced pulmonary fibrosis by inhibiting the recruitment of inflammatory cells, reducing epithelial-mesenchymal transition and TGF-β-mediated extracellular matrix production [20]. Here, TGFB1 is linked to pulmonary fibrosis.